Regulatory Aspects of Post-Approval Safety Reporting for Generic Drug Products in the US

Publisher： Bentham Science Publishers

E-ISSN： 2213-4778|3|3|142-150

ISSN： 2213-476x

Source： Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.3, Iss.3, 2016-12, pp. : 142-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-12 ,pp. : 60-68

Bentham Science Publishers

Access to resources Recommend Favorite

Belimumab Efficacy is `Mild' but Market Potential Still Great†: Anticipating US Approval of the First Lupus Drug Since 1957

By Weintraub Ben  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 203-205

Adis International

Access to resources Recommend Favorite

Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 3, 2016-02 ,pp. : 123-132

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation préclinique de la sécurité des produits issus des biotechnologies : aspects spécifiques: Preclinical Safety Evaluation of Biotechnology-Derived Products: Specific Aspects

By Descotes Jacques   Ravel Guillaume   Vial Thierry  

Therapie, Vol. 58, Iss. 2, 2003-01 ,pp. : 139-143

Adis International

Access to resources Recommend Favorite

Regulatory and Quality Aspects of Herbal Drugs

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 4, Iss. 2, 2017-08 ,pp. : 107-113

Bentham Science Publishers

Access to resources Recommend Favorite